Clinical trial sponsors should focus on data, not systems, to overcome four key challenges.
For 15 years, I worked in clinical operations at two of the world’s biggest pharmaceutical companies, Celgene and Bristol-Myers Squibb, which have recently become one. During that time, I was fortunate to bring many medical treatments to market using the latest technologies available. And while the successes far outweighed the frustrations of delayed and unsuccessful trials, I knew that our industry could better leverage technology to more quickly reach patients in need.